XML 44 R34.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Fair Value (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Fair Value Disclosures [Abstract] |
Schedule of Fair Value Assets and Liabilities | The carrying amounts and the estimated fair values of our financial instruments and certain of our nonfinancial assets measured at fair value on a recurring or non-recurring basis or disclosed, but not measured, at fair value are as follows:
|  |  | September 30, 2022 |  | December 31, 2021
| Level |  | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
Financial assets |  |  |  |  |  |  |  |  |
Loans held for sale |  |  |  |  |  |  |  |  |
Loans held for sale, at fair value (a) (e) | 3, 2 |  | $ | 725,218 |  |  | $ | 725,218 |  |  | $ | 917,534 |  |  | $ | 917,534 |
Loans held for sale, at lower of cost or fair value (b) | 3 |  | 4,420 |  |  | 4,420 |  |  | 10,993 |  |  | 10,993 |
Total Loans held for sale |  |  | $ | 729,638 |  |  | $ | 729,638 |  |  | $ | 928,527 |  |  | $ | 928,527 |
|  |  | September 30, 2022 |  | December 31, 2021
| Level |  | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
Loans held for investment |  |  |  |  |  |  |  |  |
Loans held for investment - Reverse mortgages (a) | 3 |  | $ | 7,395,483 |  |  | $ | 7,395,483 |  |  | $ | 7,199,762 |  |  | $ | 7,199,762 |
Loans held for investment - Restricted for securitization investors (a) | 3 |  | 6,802 |  |  | 6,802 |  |  | 7,879 |  |  | 7,879 |
Total loans held for investment |  |  | $ | 7,402,285 |  |  | $ | 7,402,285 |  |  | $ | 7,207,641 |  |  | $ | 7,207,641 |
Advances, net (c) | 3 |  | $ | 642,461 |  |  | $ | 642,461 |  |  | $ | 772,433 |  |  | $ | 772,433 |
Receivables, net (c) | 3 |  | 170,838 |  |  | 170,838 |  |  | 180,707 |  |  | 180,707 |
Mortgage-backed securities (a) | 3 |  | — |  |  | — |  |  | 1 |  |  | 1 |
Corporate bonds (a) | 2 |  | 211 |  |  | 211 |  |  | 211 |  |  | 211 |
Financial liabilities: |  |  |  |  |  |  |  |  |
Advance match funded liabilities (c) | 3 |  | $ | 457,452 |  |  | $ | 457,452 |  |  | $ | 512,297 |  |  | $ | 511,994 |
Financing liabilities: |  |  |  |  |  |  |  |  |
HMBS-related borrowings (a) | 3 |  | $ | 7,208,385 |  |  | $ | 7,208,385 |  |  | $ | 6,885,022 |  |  | $ | 6,885,022 |
Other financing liabilities |  |  |  |  |  |  |  |  |
Financing liability -Transferred MSR liability (a) | 3 |  | $ | 946,619 |  |  | $ | 946,619 |  |  | $ | 797,084 |  |  | $ | 797,084 |
Financing liability - Excess Servicing Spread (ESS) (a) | 3 |  | 36,301 |  |  | 36,301 |  |  | — |  |  | — |
Financing liability - Owed to securitization investors (a) | 3 |  | 6,802 |  |  | 6,802 |  |  | 7,879 |  |  | 7,879 |
Total Other financing liabilities |  |  | $ | 989,722 |  |  | $ | 989,722 |  |  | $ | 804,963 |  |  | $ | 804,963 |
Mortgage loan warehouse facilities (c) | 3 |  | 819,557 |  |  | 819,557 |  |  | 1,085,076 |  |  | 1,085,076 |
MSR financing facilities (c) (d) | 3 |  | 1,020,606 |  |  | 999,022 |  |  | 900,760 |  |  | 873,820 |
Senior notes: |  |  |  |  |  |  |  |  |
PMC Senior secured notes due 2026 (c) (d) | 2 |  | $ | 369,007 |  |  | $ | 325,736 |  |  | $ | 392,555 |  |  | $ | 413,472 |
OFC Senior secured notes due 2027 (c) (d) | 3 |  | 228,122 |  |  | 218,647 |  |  | 222,242 |  |  | 261,455 |
Total Senior notes |  |  | $ | 597,129 |  |  | $ | 544,383 |  |  | $ | 614,797 |  |  | $ | 674,927 |
Derivative financial instrument assets (liabilities), net |  |  |  |  |  |  |  |  |
Interest rate lock commitments (IRLCs) (a) | 3 |  | $ | (12,190) |  |  | $ | (12,190) |  |  | $ | 18,085 |  |  | $ | 18,085 |
Forward trades - Reverse Loans (a) | 2 |  | 87 |  |  | 87 |  |  | 364 |  |  | 364 |
TBA / Forward mortgage-backed securities (MBS) trades (a) | 1 |  | 21,769 |  |  | 21,769 |  |  | (240) |  |  | (240) |
Interest rate swap futures (a) | 1 |  | (7,274) |  |  | (7,274) |  |  | 1,734 |  |  | 1,734 |
Option contracts (a) | 2 |  | (1,172) |  |  | (1,172) |  |  | (277) |  |  | (277) |
Other (a) | 3 |  | (164) |  |  | (164) |  |  | (1,070) |  |  | (1,070) |
MSRs (a) | 3 |  | $ | 2,714,225 |  |  | $ | 2,714,225 |  |  | $ | 2,250,147 |  |  | $ | 2,250,147 |
(a)Measured at fair value on a recurring basis. (b)Measured at fair value on a non-recurring basis. (c)Disclosed, but not measured, at fair value. (d)The carrying values are net of unamortized debt issuance costs and discount. See Note 13 – Borrowings for additional information. (e)Loans repurchased from Ginnie Mae securitizations with a fair value of $30.5 million and $220.9 million at September 30, 2022 and December 31, 2021, respectively, are classified as Level 3. The remaining balance of loans held for sale at fair value is classified as Level 2.
Schedule of Reconciliation of Changes in Fair Value of Level 3 Assets and Liabilities | The following tables present a reconciliation of the changes in fair value of Level 3 assets and liabilities that we measure at fair value on a recurring basis:
|  |  |  |  | Loans Held for Investment - Restricted for Securitization Investors |  | Financing Liability - Owed to Securitization Investors |  | Loans Held for Sale - Fair Value |  |  |  | ESS Financing Liability |  | IRLCs |  |  |  |
Three months ended September 30, 2022
Beginning balance |  |  |  |  | $ | 7,289 |  |  | $ | (7,289) |  |  | $ | 41,363 |  |  |  |  | $ | — |  |  | $ | 5,746 |  |  |  |  |
Purchases, issuances, sales and settlements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases |  |  |  |  | — |  |  | — |  |  | 9,478 |  |  |  |  | — |  |  | — |  |  |  |  |
Issuances (1) |  |  |  |  | — |  |  | — |  |  | — |  |  |  |  | (36,241) |  |  | 50,912 |  |  |  |  |
Sales |  |  |  |  | — |  |  | — |  |  | (16,569) |  |  |  |  | — |  |  | — |  |  |  |  |
Settlements |  |  |  |  | (487) |  |  | 487 |  |  | — |  |  |  |  | 644 |  |  | — |  |  |  |  |
Transfers (to) from: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans held for sale, at fair value (1) |  |  |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | 17,643 |  |  |  |  |
Receivables, net |  |  |  |  | — |  |  | — |  |  | (1,581) |  |  |  |  | — |  |  | — |  |  |  |  |
|  |  |  |  | (487) |  |  | 487 |  |  | (8,672) |  |  |  |  | (35,597) |  |  | 68,555 |  |  |  |  |
Change in fair value included in earnings (1) |  |  |  |  | — |  |  | — |  |  | (2,171) |  |  |  |  | (704) |  |  | (86,491) |  |  |  |  |
Ending balance |  |  |  |  | $ | 6,802 |  |  | $ | (6,802) |  |  | $ | 30,520 |  |  |  |  | $ | (36,301) |  |  | $ | (12,190) |  |  |  |  |
|  |  |  |  | Loans Held for Investment - Restricted for Securitization Investors |  | Financing Liability - Owed to Securitization Investors |  | Loans Held for Sale - Fair Value |  | Mortgage-Backed Securities |  |  |  | IRLCs |  |  |  |
Three months ended September 30, 2021
Beginning balance |  |  |  |  | $ | 8,680 |  |  | $ | (8,680) |  |  | $ | 138,842 |  |  | $ | 1,607 |  |  |  |  | $ | 17,437 |  |  |  |  |
Purchases, issuances, sales and settlements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases |  |  |  |  | — |  |  | — |  |  | 136,996 |  |  | — |  |  |  |  | — |  |  |  |  |
Issuances (1) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 184,995 |  |  |  |  |
Sales |  |  |  |  | — |  |  | — |  |  | (64,032) |  |  | — |  |  |  |  | — |  |  |  |  |
Settlements |  |  |  |  | (676) |  |  | 676 |  |  | — |  |  | — |  |  |  |  | — |  |  |  |  |
Transfers (to) from: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans held for sale, at fair value (1) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | (182,783) |  |  |  |  |
Receivables, net |  |  |  |  | — |  |  | — |  |  | (558) |  |  | — |  |  |  |  | — |  |  |  |  |
|  |  |  |  | (676) |  |  | 676 |  |  | 72,406 |  |  | — |  |  |  |  | 2,212 |  |  |  |  |
Change in fair value included in earnings (1) |  |  |  |  | — |  |  | — |  |  | (496) |  |  | 11 |  |  |  |  | (5,619) |  |  |  |  |
Ending balance |  |  |  |  | $ | 8,004 |  |  | $ | (8,004) |  |  | $ | 210,752 |  |  | $ | 1,618 |  |  |  |  | $ | 14,030 |  |  |  |  |
|  |  |  |  | Loans Held for Investment - Restricted for Securitization Investors |  | Financing Liability - Owed to Securitization Investors |  | Loans Held for Sale - Fair Value |  |  |  | ESS Financing Liability |  | IRLCs |  |  |  |
Nine Months Ended September 30, 2022
Beginning balance |  |  |  |  | $ | 7,879 |  |  | $ | (7,879) |  |  | $ | 220,940 |  |  |  |  | $ | — |  |  | $ | 18,085 |  |  |  |  |
Purchases, issuances, sales and settlements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases |  |  |  |  | — |  |  | — |  |  | 127,715 |  |  |  |  |  |  | — |  |  |  |  |
Issuances (1) |  |  |  |  | — |  |  | — |  |  | — |  |  |  |  | (36,241) |  |  | 212,764 |  |  |  |  |
Sales |  |  |  |  | — |  |  | — |  |  | (308,181) |  |  |  |  | — |  |  | — |  |  |  |  |
Settlements |  |  |  |  | (1,077) |  |  | 1,077 |  |  | — |  |  |  |  | 644 |  |  | — |  |  |  |  |
Transfers (to) from: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans held for sale, at fair value (1) |  |  |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | (36,220) |  |  |  |  |
Receivables, net |  |  |  |  | — |  |  | — |  |  | (3,350) |  |  |  |  | — |  |  | — |  |  |  |  |
|  |  |  |  | (1,077) |  |  | 1,077 |  |  | (183,816) |  |  |  |  | (35,597) |  |  | 176,544 |  |  |  |  |
Change in fair value included in earnings (1) |  |  |  |  | — |  |  | — |  |  | (6,604) |  |  |  |  | (704) |  |  | (206,819) |  |  |  |  |
Ending balance |  |  |  |  | $ | 6,802 |  |  | $ | (6,802) |  |  | $ | 30,520 |  |  |  |  | $ | (36,301) |  |  | $ | (12,190) |  |  |  |  |
|  |  |  |  | Loans Held for Investment - Restricted for Securitization Investors |  | Financing Liability - Owed to Securitization Investors |  | Loans Held for Sale - Fair Value |  | Mortgage-backed Securities |  |  |  | IRLCs |  |
Nine Months Ended September 30, 2021
Beginning balance |  |  |  |  | $ | 9,770 |  |  | $ | (9,770) |  |  | $ | 51,072 |  |  | $ | 2,019 |  |  |  |  | $ | 22,706 |  |  |
Purchases, issuances, sales and settlements |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases |  |  |  |  | — |  |  | — |  |  | 303,117 |  |  | — |  |  |  |  | — |  |  |
Issuances (1) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 446,751 |  |  |
Sales |  |  |  |  | — |  |  | — |  |  | (135,088) |  |  | — |  |  |  |  | — |  |  |
Settlements |  |  |  |  | (1,766) |  |  | 1,766 |  |  | — |  |  | — |  |  |  |  | — |  |  |
Transfers (to) from: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans held for sale, at fair value (1) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | (425,169) |  |  |
Other assets |  |  |  |  | — |  |  | — |  |  | (377) |  |  | — |  |  |  |  | — |  |  |
Receivables, net |  |  |  |  | — |  |  | — |  |  | (1,113) |  |  | — |  |  |  |  | — |  |  |
|  |  |  |  | (1,766) |  |  | 1,766 |  |  | 166,539 |  |  | — |  |  |  |  | 21,582 |  |  |
Change in fair value included in earnings (1) |  |  |  |  | — |  |  | — |  |  | (6,859) |  |  | (401) |  |  |  |  | (30,258) |  |  |
Ending balance |  |  |  |  | $ | 8,004 |  |  | $ | (8,004) |  |  | $ | 210,752 |  |  | $ | 1,618 |  |  |  |  | $ | 14,030 |  |  |
(1)IRLC activity (issuances and transfers) represent changes in fair value included in earnings. This activity is presented on a gross basis in the table for disclosure purposes. Total net change in fair value included in earnings attributed to IRLCs is a gain (loss) of $(17.9) million and $(30.3) million for the three and nine months ended September 30, 2022, respectively, and $(3.4) million and $(8.7) million for the three and nine months ended September 30, 2021, respectively. See Note 16 – Derivative Financial Instruments and Hedging Activities.
Schedule of Significant Assumptions used in Valuation |
Significant unobservable assumptions | September 30, 2022 |  | December 31, 2021
Life in years |  |  |
Range | 0.4 to 7.2 |  | 1.0 to 8.2
Weighted average | 4.8 |  | 5.7 |
Conditional prepayment rate, including voluntary and involuntary prepayments |  |  |
Range | 13.0% to 48.1% |  | 11.2% to 36.6%
Weighted average | 18.7 | % |  | 16.0 | %
Discount rate | 5.1 | % |  | 2.6 | %
Significant unobservable assumptions | September 30, 2022 |  | December 31, 2021
Agency |  | Non-Agency |  | Agency |  | Non-Agency
Weighted average prepayment speed | 6.6 | % |  | 9.3 | % |  | 8.5 | % |  | 12.1 | %
Weighted average lifetime delinquency rate | 1.4 | % |  | 10.3 | % |  | 1.2 | % |  | 11.9 | %
Weighted average discount rate | 9.1 | % |  | 10.6 | % |  | 8.5 | % |  | 11.2 | %
Weighted average cost to service (in dollars) | $ | 72 |  |  | $ | 193 |  |  | $ | 71 |  |  | $ | 205 |
Significant unobservable assumptions | September 30, 2022 |  | December 31, 2021
Life in years |  |  |
Range | 0.4 to 7.2 |  | 1.0 to 8.2
Weighted average | 4.8 |  | 5.7 |
Conditional prepayment rate |  |  |
Range | 13.0% to 48.1% |  | 11.2% to 36.6%
Weighted average | 18.7 | % |  | 16.0 | %
Discount rate | 5.0 | % |  | 2.5 | %
Significant unobservable assumptions | September 30, 2022 |  | December 31, 2021
Weighted average prepayment speed | 8.5 | % |  | 10.9 | %
Weighted average delinquency rate | 7.2 | % |  | 8.8 | %
Weighted average discount rate | 10.1 | % |  | 10.5 | %
Weighted average cost to service (in dollars) | $ | 169 |  |  | $ | 182 |
Summary of Estimated Change in the Value of MSRs Carried at Fair Value | The following table summarizes the estimated change in the value of the MSRs as of September 30, 2022 given hypothetical increases in lifetime prepayments and yield assumptions:
Adverse change in fair value | 10% |  | 20%
Weighted average prepayment speeds | $ | (60,457) |  |  | $ | (118,162) |
Weighted average discount rate | (76,572) |  |  | (147,150) |

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a sensitivity analysis or stress test showing the hypothetical effect on the fair value of the transferor's interests in transferred financial assets (including any servicing assets or servicing liabilities) of two or more unfavorable variations from the expected levels for each key assumption that is reported, independently determined from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719 + Details
Name: | us-gaap_ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration